PL3165530T3 - Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V) - Google Patents

Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V)

Info

Publication number
PL3165530T3
PL3165530T3 PL15814466T PL15814466T PL3165530T3 PL 3165530 T3 PL3165530 T3 PL 3165530T3 PL 15814466 T PL15814466 T PL 15814466T PL 15814466 T PL15814466 T PL 15814466T PL 3165530 T3 PL3165530 T3 PL 3165530T3
Authority
PL
Poland
Prior art keywords
aryl phosphorus
spirocyclic
sulfide
aryl
oxide
Prior art date
Application number
PL15814466T
Other languages
English (en)
Polish (pl)
Inventor
Zhaozhong DING
Jinqing HU
Shuhui Chen
Xile LIU
Yidong Zhu
Chuanwen Fan
Baoping Zhao
Long Zhang
Yingying Yang
Qingmei ZHENG
Shansong ZHENG
Haiwen WAN
Jinging Hu
Original Assignee
Qilu Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410317076.7A external-priority patent/CN105330698B/zh
Application filed by Qilu Pharmaceutical Co., Ltd filed Critical Qilu Pharmaceutical Co., Ltd
Publication of PL3165530T3 publication Critical patent/PL3165530T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65615Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing a spiro condensed ring system of the formula where at least one of the atoms X or Y is a hetero atom, e.g. S

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL15814466T 2014-07-04 2015-06-29 Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V) PL3165530T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410317076.7A CN105330698B (zh) 2014-07-04 2014-07-04 螺环芳基磷氧化物和硫化物
CN201510350019 2015-06-23
EP15814466.7A EP3165530B1 (en) 2014-07-04 2015-06-29 Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
PCT/CN2015/082605 WO2016000581A1 (zh) 2014-07-04 2015-06-29 螺环芳基磷氧化物和芳基磷硫化物

Publications (1)

Publication Number Publication Date
PL3165530T3 true PL3165530T3 (pl) 2019-07-31

Family

ID=55018447

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15814466T PL3165530T3 (pl) 2014-07-04 2015-06-29 Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V)

Country Status (7)

Country Link
US (1) US10053477B2 (https=)
EP (1) EP3165530B1 (https=)
JP (1) JP6487527B2 (https=)
ES (1) ES2714576T3 (https=)
PL (1) PL3165530T3 (https=)
TW (1) TWI571471B (https=)
WO (1) WO2016000581A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053477B2 (en) 2014-07-04 2018-08-21 Qilu Pharmaceutical Co., Ltd. Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
WO2018133829A1 (zh) * 2017-01-23 2018-07-26 南京明德新药研发股份有限公司 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物
JP7166331B2 (ja) * 2017-08-01 2022-11-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 中間体化合物及び方法
CN109369721B (zh) * 2017-12-21 2024-05-14 深圳市塔吉瑞生物医药有限公司 用于抑制激酶活性的芳基磷氧化物
JP7043098B2 (ja) * 2017-12-21 2022-03-29 深▲チェン▼市塔吉瑞生物医薬有限公司 キナーゼ活性を阻害するためのジアニリノピリミジン系化合物
US11046720B2 (en) * 2018-04-20 2021-06-29 Guizhou Inochini Technology Co., Ltd Dimethylphosphine oxide compound
US20220064196A1 (en) * 2019-01-17 2022-03-03 Betta Pharmaceuticals Co., Ltd. EGFR Inhibitors, Compositions and Methods Thereof
JP7554829B2 (ja) 2019-12-19 2024-09-20 ヤンセン ファーマシューティカ エヌ.ベー. 置換直鎖スピロ誘導体
EP4306115A4 (en) * 2021-07-05 2024-11-20 Qilu Pharmaceutical Co., Ltd. Pharmaceutical composition, and preparation method therefor and application thereof
TW202319050A (zh) * 2021-11-05 2023-05-16 大陸商南京明德新藥研發有限公司 氮雜螺環化合物
TW202333728A (zh) * 2022-01-18 2023-09-01 大陸商齊魯製藥有限公司 螺環芳基磷氧化物與抗vegf抗體的聯用藥物組合物及其用途
TW202339767A (zh) * 2022-01-18 2023-10-16 大陸商齊魯製藥有限公司 螺環芳基磷氧化物與抗egfr抗體的聯用藥物組合物及其用途
CN118891264A (zh) * 2022-08-01 2024-11-01 齐鲁制药有限公司 螺环胺类芳基磷氧化合物的晶型及其制备方法
WO2025202955A1 (en) 2024-03-28 2025-10-02 Pi Industries Ltd. Fused bicyclic compounds and their use as pest control agents

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
TWI389893B (zh) * 2007-07-06 2013-03-21 Astellas Pharma Inc 二(芳胺基)芳基化合物
US9273077B2 (en) * 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
PT2300013T (pt) 2008-05-21 2017-10-31 Ariad Pharma Inc Derivados de fósforo como inibidores de cinases
EP2496574A1 (en) * 2009-11-02 2012-09-12 Abbott Laboratories Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
WO2011146945A2 (en) * 2010-05-21 2011-11-24 Cell Signaling Technology, Inc. Alk and ros kinase in cancer
BR112013008816A2 (pt) 2010-10-14 2016-06-28 Ariad Pharma Inc método de tratamento de câncer direcionado ao egfr resistente à erlotinibe ou gefitinibe, ou uso de um sal farmacêuticamente aceito em um indivíduo
FR2974088A1 (fr) 2011-04-12 2012-10-19 Pf Medicament Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
CN102731413A (zh) 2011-04-15 2012-10-17 上海医药工业研究院 一种脲类化合物、其制备方法、其中间体及其应用
WO2013138210A1 (en) 2012-03-14 2013-09-19 Ning Xi Substituted cyclic compounds and methods of use
EP2831061A1 (en) 2012-03-28 2015-02-04 Synta Pharmaceuticals Corp. Triazole derivatives as hsp90 inhibitors
US20150166591A1 (en) * 2012-05-05 2015-06-18 Ariad Pharmaceuticals, Inc. Methods and compositions for raf kinase mediated diseases
US20130310340A1 (en) * 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
WO2013177092A1 (en) 2012-05-23 2013-11-28 Sunshine Lake Pharma Co., Ltd. Substituted alkynyl pyridine compounds and methods of use
WO2013192512A1 (en) 2012-06-22 2013-12-27 Concert Pharmaceuticals, Inc. Derivatives of pyrazole-substituted amino-heteroaryl compounds
WO2014002922A1 (ja) 2012-06-26 2014-01-03 アステラス製薬株式会社 抗癌剤の併用による癌治療方法
SG11201408816QA (en) 2012-07-03 2015-03-30 Aurigene Discovery Tech Ltd 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
KR101446742B1 (ko) 2012-08-10 2014-10-01 한국화학연구원 N2,n4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
AU2013307383A1 (en) 2012-08-27 2015-03-26 Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh Aminoheteroaryl compounds as MTH1 inhibitors
US10053477B2 (en) 2014-07-04 2018-08-21 Qilu Pharmaceutical Co., Ltd. Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide

Also Published As

Publication number Publication date
TWI571471B (zh) 2017-02-21
EP3165530A1 (en) 2017-05-10
JP2017521436A (ja) 2017-08-03
US10053477B2 (en) 2018-08-21
US20170129909A1 (en) 2017-05-11
EP3165530B1 (en) 2018-12-05
JP6487527B2 (ja) 2019-03-20
EP3165530A4 (en) 2017-07-26
ES2714576T3 (es) 2019-05-29
WO2016000581A1 (zh) 2016-01-07
TW201604202A (zh) 2016-02-01

Similar Documents

Publication Publication Date Title
PL3165530T3 (pl) Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V)
GB201708754D0 (en) Neuromodulation device
PL3119688T3 (pl) Zamknięcie
SG11201610831PA (en) Lithium-sulphur battery
GB201418399D0 (en) Traction control
SG10201509851YA (en) Travel facility
GB2525943B (en) Oven
ZA201703835B (en) Zinc phosphate complex
ZA201605262B (en) Closure assembly
IL238369A0 (en) Silicon compounds with functional azocarbonyl
PL3085669T3 (pl) Złożony tlenek litu
ZA201703728B (en) Zinc phosphate complex
GB201407161D0 (en) Linear accelerator
PL3033968T3 (pl) Piekarnik
PL3099980T3 (pl) Piekarnik
GB201404253D0 (en) Closure assembly
ZA201700156B (en) Closure
GB201411985D0 (en) Battery
GB201420268D0 (en) Closure
AU2014117V (en) Calkwr Callistemon hybrid
GB2554909B (en) Dexterity assessment
AU5490P (en) WES08 Westringia hybrid
GB201416094D0 (en) Tamper-proof cover
GB201417027D0 (en) Journey logger
GB201416510D0 (en) Charge buddies